Pediatrix Medical Group, Inc. (MD)
(Delayed Data from NYSE)
$10.48 USD
-0.08 (-0.76%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $10.48 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Income Statements
Fiscal Year end for Pediatrix Medical Group, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,995 | 1,972 | 1,911 | 1,734 | 3,514 |
Cost Of Goods | 1,573 | 1,505 | 1,398 | 1,285 | 2,622 |
Gross Profit | 422 | 467 | 513 | 449 | 892 |
Selling & Adminstrative & Depr. & Amort Expenses | 414 | 294 | 310 | 351 | 2,028 |
Income After Depreciation & Amortization | 7 | 173 | 203 | 98 | -1,136 |
Non-Operating Income | -14 | -52 | 1 | 20 | 13 |
Interest Expense | 42 | 40 | 69 | 110 | 119 |
Pretax Income | -48 | 81 | 135 | 7 | -1,242 |
Income Taxes | 12 | 19 | 27 | 17 | -92 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -60 | 63 | 108 | -10 | -1,150 |
Extras & Discontinued Operations | 0 | 4 | 23 | -787 | -348 |
Net Income (GAAP) | -60 | 66 | 131 | -796 | -1,498 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 45 | 210 | 239 | 134 | 398 |
Depreciation & Amortization (Cash Flow) | 37 | 37 | 36 | 36 | 1,534 |
Income After Depreciation & Amortization | 7 | 173 | 203 | 98 | -1,136 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 82.20 | 84.12 | 85.83 | 83.40 | 83.50 |
Diluted EPS Before Non-Recurring Items | 1.15 | 1.54 | 1.51 | 0.76 | 3.14 |
Diluted Net EPS (GAAP) | -0.73 | 0.79 | 1.53 | -9.55 | -17.94 |
Fiscal Year end for Pediatrix Medical Group, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 504.30 | 495.10 | 496.44 | 506.61 | 500.58 |
Cost Of Goods | 390.18 | 400.22 | 395.28 | 399.72 | 385.12 |
Gross Profit | 114.12 | 94.88 | 101.17 | 106.89 | 115.46 |
SG&A, R&D, and Dept/Amort Expenses | 271.84 | 78.99 | 210.43 | 66.62 | 66.96 |
Income After SG&A, R&D, and Dept/Amort Expenses | -157.72 | 15.89 | -109.26 | 40.27 | 48.50 |
Non-Operating Income | 0.30 | 2.53 | 2.72 | 0.93 | 1.68 |
Interest Expense | 10.31 | 10.60 | 10.08 | 10.37 | 11.23 |
Pretax Income | -167.73 | 7.82 | -138.85 | 30.83 | 38.95 |
Income Taxes | -14.70 | 3.79 | -14.56 | 9.44 | 10.67 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -153.03 | 4.04 | -124.29 | 21.39 | 28.28 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -153.03 | 4.04 | -124.29 | 21.39 | 28.28 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 83.33 | 83.28 | 82.66 | 82.95 | 82.66 |
Diluted EPS Before Non-Recurring Items | 0.32 | 0.17 | 0.29 | 0.29 | 0.37 |
Diluted Net EPS (GAAP) | -1.84 | 0.05 | -1.50 | 0.26 | 0.34 |